TY - JOUR
T1 - Pituitary Pseudotumor
T2 - Mimicry of Recurrent Prolactinoma by a Chronic Intrasellar Hematoma
AU - Veldhuis, Johannes D.
AU - Santen, Richard J.
N1 - Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 1979/11
Y1 - 1979/11
N2 - In the increasing cohort of patients being observed after pituitary microneurosurgery for prolactin-secreting adenomas, tumor recurrence remains a concern. We describe a patient with a prolactinoma treated by transsphenoidal pituitary surgery who resumed cyclic menses for one year postoperatively before manifesting progressive headaches, intermittent diplopia, secondary amenorrhea, and anterior pituitary failure. Invasive and noninvasive neuroradiologic procedures suggested recurrent tumor with suprasellar extension. However, reoperation of the pituitary disclosed a chronic intrasellar hematoma expanding under increased pressure within the enclosed sellar space. We discuss a putative mechanism for the pathophysiology of this syndrome, and tentatively designate it “pituitary pseudotumor.“ Recognition of this entity is important not only because reoperation is required for accurate diagnosis, but also because treatment with radiotherapy or bromocriptine mesylate for presumptive tumor progression or recurrence would be ineffective.
AB - In the increasing cohort of patients being observed after pituitary microneurosurgery for prolactin-secreting adenomas, tumor recurrence remains a concern. We describe a patient with a prolactinoma treated by transsphenoidal pituitary surgery who resumed cyclic menses for one year postoperatively before manifesting progressive headaches, intermittent diplopia, secondary amenorrhea, and anterior pituitary failure. Invasive and noninvasive neuroradiologic procedures suggested recurrent tumor with suprasellar extension. However, reoperation of the pituitary disclosed a chronic intrasellar hematoma expanding under increased pressure within the enclosed sellar space. We discuss a putative mechanism for the pathophysiology of this syndrome, and tentatively designate it “pituitary pseudotumor.“ Recognition of this entity is important not only because reoperation is required for accurate diagnosis, but also because treatment with radiotherapy or bromocriptine mesylate for presumptive tumor progression or recurrence would be ineffective.
UR - http://www.scopus.com/inward/record.url?scp=0018591128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018591128&partnerID=8YFLogxK
U2 - 10.1001/archinte.1979.03630480081025
DO - 10.1001/archinte.1979.03630480081025
M3 - Article
C2 - 508030
AN - SCOPUS:0018591128
SN - 2168-6106
VL - 139
SP - 1309
EP - 1311
JO - Archives of internal medicine (Chicago, Ill. : 1908)
JF - Archives of internal medicine (Chicago, Ill. : 1908)
IS - 11
ER -